Eastern Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1K Hold
228
﹤0.01% 668
2026
Q1
$29.1K Sell
228
-106
-32% -$13.2K ﹤0.01% 662
2025
Q4
$40.7K Sell
334
-2
-0.6% -$229 ﹤0.01% 610
2025
Q3
$33.7K Sell
336
-100
-23% -$9.01K ﹤0.01% 629
2025
Q2
$36.2K Sell
436
-16
-4% -$1.28K ﹤0.01% 596
2025
Q1
$36.7K Sell
452
-21
-4% -$1.88K ﹤0.01% 588
2024
Q4
$42.6K Sell
473
-114
-19% -$11K ﹤0.01% 588
2024
Q3
$58K Buy
+587
New +$57.7K ﹤0.01% 543
2024
Q1
Sell
-4,343
Closed -$388K 213
2023
Q4
$388K Sell
4,343
-134,878
-97% -$10M 0.02% 169
2023
Q3
$10.2M Sell
139,221
-45
-0% -$3.6K 0.51% 69
2023
Q2
$11.6M Buy
139,266
+623
+0.4% +$52.1K 0.55% 68
2023
Q1
$10.6M Buy
+138,643
New +$11.5M 0.53% 71
2022
Q1
Sell
-7,079
Closed -$793K 209
2021
Q4
$793K Sell
7,079
-5,257
-43% -$634K 0.03% 146
2021
Q3
$1.55M Sell
12,336
-2,920
-19% -$376K 0.07% 112
2021
Q2
$2.07M Sell
15,256
-175,330
-92% -$23.1M 0.1% 108
2021
Q1
$25.9M Sell
190,586
-26,379
-12% -$3.95M 1.4% 20
2020
Q4
$30.5M Sell
216,965
-10,689
-5% -$1.37M 1.71% 11
2020
Q3
$25.4M Sell
227,654
-5,557
-2% -$623K 1.55% 13
2020
Q2
$26.1M Sell
233,211
-9,589
-4% -$944K 1.7% 12
2020
Q1
$18.8M Sell
242,800
-8,533
-3% -$756K 1.4% 17
2019
Q4
$23.9M Buy
251,333
+7,386
+3% +$639K 1.39% 18
2019
Q3
$18.6M Buy
243,947
+5,417
+2% +$450K 1.16% 27
2019
Q2
$20.9M Buy
238,530
+8,857
+4% +$755K 1.33% 18
2019
Q1
$20.8M Sell
229,673
-3,062
-1% -$260K 1.39% 17
2018
Q4
$16.7M Buy
+232,735
New +$18.8M 1.25% 24

Other funds holding XBI

Eastern Bank's XBI Position: Q2 2026 in Review

Eastern Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 228 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Eastern Bank first reported a position in XBI in Q4 2018 and has held it in 25 quarters since. The position peaked at $30.5M in Q4 2020. 115 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Eastern Bank held 228 shares of State Street SPDR S&P Biotech ETF worth $36.1K as of Q2 2026.
  • Eastern Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #668 holding.
  • Eastern Bank first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 25 quarters since.
  • Eastern Bank's State Street SPDR S&P Biotech ETF position peaked at $30.5M in Q4 2020.
  • 115 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.